Phibro Animal Health reported $52.43M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Align Technology ALGN:US $ 426.4M 13.06M
Ani Pharmaceuticals ANIP:US $ 28.82M 1.89M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Bristol Myers Squibb BMY:US $ 1.78B 46M
Corcept Therapeutics CORT:US $ 37.81M 264K
Depomed DEPO:US $ 10.44M 2.84M
Eli Lilly And LLY:US $ 1.63B 67.2M
Endo International Ordinary Shares ENDP:US 226M 18.48M
Henry Schein HSIC:US $ 680M 2M
Idexx Laboratories IDXX:US $ 211.74M 1.5M
JAZZ PHA JAZZ:US 325.67M 16.86M
Knight Therapeutics Inc GUD:CN C$ 18.52M 3.77M
Lannett LCI:US $ 17.57M 1.22M
Merk MRK:US $ 2.42B 118M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Phibro Animal Health PAHC:US $ 52.43M 4.05M
Prestige Brands PBH:US $ 66.66M 1.92M
Supernus Pharmaceuticals SUPN:US $ 100.48M 10.02M
Teva Pharmaceutical Industries TEVA:US 849M 30M
Zoetis ZTS:US $ 529M 64M